The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

Monash University and Monash Health are collaborating on projects that aim to develop the first effective drug for two types of high cholesterol that until now have had no effective treatment. The ...

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.

The highest dose of an experimental pill developed by Eli Lilly dramatically lowered an inherited form of high cholesterol in ...

Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...

Using a longitudinal study of mice fed high-fat diets—with no additional cholesterol—the team tracked how these ... we can ...

Lilly’s drug is the only oral treatment in a field of several injectable therapies being tested to treat high Lp(a), a risk ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

Managing diabetes and high cholesterol often requires lifestyle changes, such as eating healthier, exercising, and sometimes ...

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...

When you've got hyperlipidemia—that's the fancy term for high cholesterol—those extra lipids begin clogging up your arteries. The Cleveland Clinic has broken it down: think of these lipids ...